Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection

NCT ID: NCT04432922

Last Updated: 2023-06-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-11-01

Study Completion Date

2020-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to analyze the perceptions, representations and experiences of septic isolation of patients hospitalized for COVID-19 infection.

This analysis could lead to better understanding and communication between the medical profession and patients in septic isolation in hospital. It would also provide patient-specific responses to their expectations, as to their families.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

SARS-Cov2 is a new virus responsible for the COVID-19 pandemic. For the first time, it was observed in Wuhan, China in December 2019. For this previously unknown contagious disease, which can cause severe respiratory infections, isolation precautions in hospitals and public places are one of the cornerstones for fighting this pandemic.

Hospital isolation precautions have been present since the 19th century as a means to control the spread of infections. Septic isolation includes contact isolation, droplets and air. Isolation precautions must be prescribed by a physician. To our knowledge, there are few studies about the impact of septic isolation on hospitalized patients at both the psychological level and the relationship with doctors.

This study could enable a better understanding and communication between the medical profession and patients in septic isolation during hospitalization. It could also provide patient-specific responses to their expectations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hospitalized Patients for COVID-19 Infection

Face to face semi-directed interviews about perceptions, representations and experiences of septic isolation, including nine opened-questions.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Major patients
* Living in metropolitan France during the SARS-CoV2 pandemic
* Being or having been hospitalized in isolation contact and droplet for a COVID-19 infection (proven or suspected)
* Being in the process of leaving hospital
* Ready for No Opposition for Participation in the Protocol

Exclusion Criteria

* Patients under guardianship or curatorship
* Patients unable to give free and informed consent;
* Patients under safeguarding justice
* Hospitalized patients on oxygen therapy with speech dyspnea
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Intercommunal Creteil

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre hospitalier intercommunal de Villeneuve St Georges

Villeneuve-Saint-Georges, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ISOCOV

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.